Clinical Trial Update: Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma [Phase 3]

View source ↗

Summary

Phase III trial of rindopepimut/GM-CSF in newly diagnosed glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• rindopepimut/GM-CSF (rindopepimut)

Snippet

Sponsor: Celldex Therapeutics | Conditions: Glioblastoma, Small Cell Glioblastoma | Phase 3 | Status: COMPLETED